Related Articles
Absence of differences in the recurrence rates of hepatitis C virus‑associated hepatocellular carcinoma between direct‑acting antivirals and interferon‑based treatments: A multicenter study
Programmed death‑ligand 1 expression is an unfavorable prognostic factor of hepatocellular carcinoma after archiving sustained virologic response for hepatitis C virus infection
Interval between hepatocellular carcinoma treatment and interferon‑free direct‑acting antiviral agents against hepatitis C is necessary to suppress tumor recurrence
Effect of HCV treatment response on insulin resistance: A systematic review and meta‑analysis Corrigendum in /10.3892/etm.2019.8334
Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders